The importance of 24-hour ambulatory blood pressure monitoring in patients at risk of cardiovascular events

High Blood Pressure and Cardiovascular Prevention

Volumn 20, Issue 1, 2013, Pages 13-18

  Redon, Josep ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

ABPM; Cardiovascular; Smoothness index; Telmisartan

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; TELMISARTAN;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; ESSENTIAL HYPERTENSION; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HUMAN; MASKED HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUDDEN CARDIAC DEATH; SUDDEN DEATH; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TIME FACTORS;

EID: 84879358997     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.1007/s40292-013-0006-3     Document Type: Review

References (35)

1. Dawber TR, Kannel WB, Revotskie N, et al. The epidemiology of coronary heart disease: the Framingham enquiry. Proc R Soc Med. 1962;55:265-71.
2. Pickering T. Ambulatory blood pressure monitoring: an historical perspective. Clin Cardiol 1992;15:II3-II5.
3. Stanton A, O'Brien E. Noninvasive 24 hour ambulatory blood pressure monitoring: current status. Postgrad Med J. 1993;69:255-67.
4. Mancia G, Omboni S, Parati G. The importance of blood pressure variability in hypertension. Blood Press Monit. 2000;5(Suppl 1):S9-15.
5. Mancia G, Parati G, Pomidossi G, et al. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension. 1987;9:209-15.
6. Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54:226-32.
7. Hinman AT, Engel BT, Bickford AF. Portable blood pressure recorder: accuracy and preliminary use in evaluating intradaily variations in pressure. Am Heart J. 1962;63:663-8.
8. Sokolow M, Werdegar D, Kain HK, et al. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation. 1966;34:279-98.
9. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens Suppl. 2005;23:S19-25.
10. Mancia G, Bombelli M, Facchetti R, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007;49:1265-70.
11. Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000;36:901-6.
12. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539-46.
13. Omboni S, Parati G, Mancia G. The trough:peak ratio and the smoothness index in the evaluation of control of 24 h blood pressure by treatment in hypertension. Blood Press Monit. 1998;3:201-4.
14. Parati G, Omboni S, Rizzoni D, et al. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens. 1998;16:1685-91.
15. Parati G, Schumacher H, Bilo G, et al. Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database. J Hypertens. 2010;28:2177-83.
16. Rizzoni D, Muiesan ML, Salvetti M, et al. The smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatment. J Hypertens. 2001;19:703-11.
17. Campo C, Saavedra J, Segura J, et al. Correlations of smoothness index and trough-to-peak ratio with left ventricular mass index changes induced by lercanidipine in hypertensive patients: a pilot trial. Minerva Med. 2005;96:365-71.
18. White WB. Ambulatory blood-pressure monitoring in clinical practice. N Engl J Med. 2003;348:2377-8.
19. Longo D, Dorigatti F, Palatini P. Masked hypertension in adults. Blood Press Monit. 2005;10:307-10.
20. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313:1315-22.
21. Willich SN, Goldberg RJ, Maclure M, et al. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol. 1992;70:65-8.
22. Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance of night-time, early morning, and daytime blood pressures on the risk of cerebrovascular and cardiovascular mortality: the Ohasama Study. J Hypertens. 2006;24:1841-8.
23. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401-6.
24. Frattola A, Parati G, Cuspidi C, et al. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993;11:1133-7.
25. Redon J, Bilo G, Parati G. Home blood pressure control is low during the critical morning hours in patients with hypertension: the SURGE observational study. Fam Pract. 2011;29:421-6.
26. Parati G, Bilo G, Redon J. Morning and smooth 24-hour ambulatory blood pressure control is not achieved in general practice: results from the SURGE observational study. J Hypertens. 2013;616-23.
27. Shimada K, Fujita T, Ito S, et al. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study. Hypertens Res. 2008;31:1903-11.
28. Obara T, Ohkubo T, Kikuya M, et al. Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study. Blood Press Monit. 2005;10:311-6.
29. Banegas JR, Segura J, Sobrino J, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49:62-8.
30. Redon J, Roca-Cusachs A, Mora-Macia J. Uncontrolled early morning blood pressure in medicated patients: the ACAMPA study. Analysis of the Control of Blood Pressure using Abulatory Blood Pressure Monitoring. Blood Press Monit. 2002;7:111-6.
31. Parati G, Bilo G, Redon J. The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2). Hypertens Res. 2012 [Epub ahead of print].
32. Conway J, Johnston J, Coats A, et al. The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents. J Hypertens. 1988;6:111-6.
33. Conway J, Coats A. Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens Suppl. 1989;7:S29-32.
34. Dolan E, Stanton AV, Thom S, et al. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients: an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens. 2009;27:876-85.
35. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895-906.